Serotonin transporter production and degradation rates: Studies with RTI-76

Brain Research

Volumn 841, Issue 1-2, 1999, Pages 1-10

  Vicentic, Aleksandra ^b   Battaglia, George ^b   Ivy Carroll, F ^c   Kuhar, Michael J ^a  

^a EMORY UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c NONE

Author keywords

5 HT reuptake; 5 HT transporter; Cocaine; Dopamine transporter; Irreversible antagonist; Turnover

Indexed keywords

3BETA (4 CHLOROPHENYL) 2BETA TROPANECARBOXYLIC ACID 4 ISOTHIOCYANATO PHENYLETHYL ESTER; 3BETA (4 CHLOROPHENYL)TROPAN 2BETA CARBOXYLIC ACID 4 ISOTHIOCYANATOPHENETHYL ESTER; CITALOPRAM; COCAINE; FLUOXETINE; PARGYLINE; PAROXETINE; SEROTONIN CREATININE SULFATE; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIGAND BINDING; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; RECEPTOR DENSITY; SEROTONINERGIC TRANSMISSION;

ANIMALS; CARRIER PROTEINS; CEREBRAL CORTEX; CEREBRAL VENTRICLES; CITALOPRAM; COCAINE; HALF-LIFE; INJECTIONS, INTRAVENTRICULAR; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TROPANES;

EID: 0033546936     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01761-8     Document Type: Article

References (40)

1. Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16:1993;73-93.
2. Battaglia G., Norman A.B., Creese I. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment. J. Pharmacol. Exp. Ther. 243:1987;69-75.
3. 3H ]paroxetine-labeled serotonin uptake sites J. Pharmacol. Exp. Ther. 242:1987;911-916.
4. Belej T., Manji D., Sioutis S., Barros H.M., Nobrega J.N. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects. Brain Res. 736:1996;287-296.
5. Boja J.W., Rahman A.M., Philip A., Lewin A.H., Carroll F.I., Kuhar M.J. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter. Molecular Pharmacology. 39:1990;339-345.
6. Carroll F.I., Gao Y., Abraham P., Lewin A.H., Lew R., Patel A., Boja J.W., Kuhar M.J. Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. J. Med. Chem. 35:1992;1813-1817.
7. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H., Gill P., Aitchison K.J., Sodhi M., Li T., Roberts G.W., Smith B., Morton J., Murray R.M., Smith D., Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 7:1996;1675-1679.
8. D'Amato R.J., Blue M.E., Largent B.L., Lynch D.R., Ledbetter D.J., Molliver M.E., Snyder S.H. Ontogeny of the serotonergic projections to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4322-4326.
9. 3H -paroxetine-labeled serotonin uptake sites in rat brain Synapse. 1:1987;488-496.
10. Fleckenstein A.E., Pogun S., Carroll F.I., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J. Pharmacol. Exp. Ther. 279:1996;200-206.
11. Fuller R.W. Minireview: uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55:1994;163-167.
12. Gozlan H., Laporte A.M., Thibault S., Schechter L.E., Bolanos F., Hamon M. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33:1994;423-431.
13. 3H ]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain Neuropsychopharmacology. 14:1996;309-323.
14. 3H ]imipramine recognition sites in rat brain by chronic treatment with antidepressants European Journal of Pharmacology. 138:1987;159-168.
15. Huether G., Zhou D., Schmidt S., Wiltfang J., Ruther E. Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex. Biological Psychiatry. 41:1997;1174-1180.
16. Imai H., Steindler D.A., Kitai S.T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:1986;363-380.
17. Jacobs B.L., Wise W.D., Taylor K.M. Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res. 79:1974;353-361.
18. Kitayama S., Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Japanese Journal of Pharmacology. 72:1996;195-208.
19. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269:1994;1268-1279.
20. Kuhar M.J., Roth R.H., Aghajanian G.K. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J. Pharmacol. Exp. Ther. 181:1972;36-45.
21. Lesch K.P., Aulakh C.S., Wolozin B.L., Murphy D.L. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression. Pharmacology and Toxicology. 71:1992;49-60.
22. Lesch K.P., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Murphy D.L. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res. Mol. Brain Res. 17:1993;31-35.
23. Lowry O.H., Rosebrough A.L., Farr A.L., Randall R.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 93:1951;265-275.
24. Meller E., Bohmaker K., Namba Y., Friedhoff A.J., Goldstein M. Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol. Pharmacol. 31:1987;592-597.
25. Meltzer H.Y. Role of serotonin in depression. Annals of the New York Academy of Sciences. 600:1990;486-499. Discussion 499-500.
26. Molliver M.E. Serotonergic neuronal systems: what their anatomical organization tells us about function. J. Clin. Psychopharmacol. 7:1983;3S-23S.
27. Morikawa O., Sakai N., Obara H., Saito N. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. European Journal of Pharmacology. 349:1998;317-324.
28. Norman A.B., Battaglia G., Creese I. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms. Journal of Neuroscience. 7:1987;1484-1491.
29. Pinto W., Battaglia G. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Neuroreport. 5:1993;61-64.
30. Pinto W., Battaglia G. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation. Molecular Pharmacology. 46:1994;1111-1119.
31. Ramamoorthy S., Ramamoorthy J.D., Prasad P.D., Bhat G.K., Mahesh V.B., Leibach F.H., Ganapathy V. Regulation of the human serotonin transporter by interleukin-1 beta. Biochemical and Biophysical Research Communications. 216:1995;560-567.
32. Rattray M., Baldessari S., Gobbi M., Mennini T., Samanin R., Bendotti C. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. Journal of Neurochemistry. 67:1996;463-472.
33. Ross S.B., Renyi A.L. Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci. 6:1967;1407-1415.
34. Slotkin T.A., McCook E.C., Ritchie J.C., Carroll B.J., Seidler F.J. Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biological Psychiatry. 41:1997;172-183.
35. Tate C.G., Blakely R.D. The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J. Biol. Chem. 269:1994;26303-26310.
36. A. Vicentic, F.I. Carroll, G. Battaglia, M.J. Kuhar, Brain Serotonin transporter production and degradation: studies with RTI-76. NIDA Research Monograph, Vol. 179, Proceedings of the 60th Annual Sci. Meeting.
37. A. Vicentic, F.I. Carroll, G. Battaglia, M.J. Kuhar, Serotonin transporter production and degradation: studies with RTI-76., 28th Annual Meeting Society for Neuroscience, Vol. 24, (1) Los Angeles, CA, 1998, pp. 1115.
38. Watanabe Y., Sakai R.R., McEwen B.S., Mendelson S. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res. 615:1993;87-94.
39. Wolf W.A., Kuhn D.M. Role of essential sulfhydryl groups in drug interactions at the neuronal 5-HT transporter. Differences between amphetamines and 5-HT uptake inhibitors. J. Biol. Chem. 267:1992;20820-20825.
40. Zimanyi I., Jacobson A.E., Rice K.C., Lajtha A., Reith M.E.A. Long-term blockade of the dopamine uptake complex by metaphit, an isothiocyanate derivative of phencyclidine. Synapse. 3:1986;239-245.